Microbiológica's GMP synthetic active-pharmaceutical-ingredient line for human use, produced via validated synthetic procedures.
Microbiológica's synthetic-API line covers GMP industrial production of active pharmaceutical ingredients for human use via validated synthetic procedures, including entecavir, sofosbuvir, azathioprine, mercaptopurine, thalidomide and tioguanine, plus pharmaceutical reference standards.
The offering competes with Cristália's chemical active-pharmaceutical-ingredients unit in the Brazilian synthetic-API market.
| Attribute | Microbiológica Synthetic Active Pharmaceutical Ingredients | Chemical Active Pharmaceutical Ingredients | |
|---|---|---|---|
| Provider | |  | |
| Founded | — | 1972 | |
| Sells To | — | Consumers, Hospitals | |
| Pricing Model | — | Product Sales | |
| Ownership | — | Private |
Provider
Founded —
Sells To —
Pricing Model —
Ownership —
Provider
Founded 1972
Sells To Consumers, Hospitals
Pricing Model Product Sales
Ownership Private
Nortec Química's active-pharmaceutical-ingredient (IFA) manufacturing line: 50+ GMP APIs including esketamine, bupivacaine and olanzapine.
Blau FarmacêuticaBlau Farmacêutica's active-pharmaceutical-ingredient (IFA) production, including a dedicated high-complexity biotech raw-materials plant.
Cristália's biological-ingredients operation, the first Brazilian pharmaceutical plant certified by Anvisa under CBPF standards.
Nortec Química's active-pharmaceutical-ingredient (IFA) manufacturing line: 50+ GMP APIs including esketamine, bupivacaine and olanzapine.
Blau Farmacêutica's active-pharmaceutical-ingredient (IFA) production, including a dedicated high-complexity biotech raw-materials plant.
Blau FarmacêuticaCristália's biological-ingredients operation, the first Brazilian pharmaceutical plant certified by Anvisa under CBPF standards.